| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699160 | Clinical Oncology | 2009 | 4 Pages |
Abstract
Although it may be argued that single fraction (SF) radiotherapy (RT) should be regarded as the standard palliative treatment for pain due to uncomplicated bone metastases, its widespread clinical use is still underexploited. In this chapter, the authors discuss a number of surveys investigating doctors and patients' preferences for palliative RT schedules, discuss the possible reasons for this phenomenon, and suggest potential strategies to increase the use of SF.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Y. van der Linden, D. Roos, S. Lutz, A. Fairchild,